Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...

Membrane proteins play an essential role in countless biological processes and are pivotal targets in drug discovery. However, their inherent amphipathic nature necessitates the development of ...

Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at ...

Protein therapeutics have transformed modern medicine through precisely engineered molecules that offer targeted treatment options in a range of diseases. Advances in formulation strategies, stability ...

Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at the University of Massachusetts Amherst, could have applications beyond ...

Global agrifood systems are changing rapidly, driven by factors such as climate change. These changes can have adverse ramifications in terms of both access to and the availability of nutritious foods ...

Protein-degrader structure and function have been captured in unprecedented detail. Protein degraders are recognized as an exciting avenue for drug discovery and development, providing targeted ...

Techniques such as protein expression, purification, quantification and processing for proteomic analysis have become routine. As mass spectrometry has become faster, cheaper, and more powerful, ...

KANSAS CITY — Precision fermentation and canola protein may accelerate plant protein innovation. Seaweed protein also may make a splash in the future. The plant protein category by no means has stayed ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. To function well, the human body requires an adequate ...

Solving the structure of an amyloid protein gives new insight into limb-girdle muscular dystrophy type 3 (LGMD D3) and functional protein aggregation. LGMD D3 is a rare disease characterized by slow ...

Food-tech company Oobli is making progress on further commercializing its sweet protein with a partnership with Ingredion and $18 million in Series B1 funding In a 48-hour research and development ...